Shujing Xu

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, Shandong Key Laboratory Of Druggability Optimization And Evaluation For Lead Compounds, 250012 Jinan, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug Resistance.

Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug Resistance.

Journal: Journal of medicinal chemistry

Published: July 13, 2026

Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia.

Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

Engineered biohybrids for photothermally enhanced chemodynamic-immunotherapy through reprograming immunosuppressive microenvironment and inhibiting immune evasion.

Engineered biohybrids for photothermally enhanced chemodynamic-immunotherapy through reprograming immunosuppressive microenvironment and inhibiting immune evasion.

Journal: Journal of colloid and interface science

Published: December 31, 2025

Recent Advances in Long-Acting Antiviral Agents: Innovations in Design and Strategies for Extended Duration.

Recent Advances in Long-Acting Antiviral Agents: Innovations in Design and Strategies for Extended Duration.

Journal: Journal of medicinal chemistry

Published: December 17, 2025

An engineered microbial nanohybrid for enhanced photothermal-chemodynamic therapy through controlled gas generation.

An engineered microbial nanohybrid for enhanced photothermal-chemodynamic therapy through controlled gas generation.

Journal: Journal of colloid and interface science

Published: April 29, 2025

Design, synthesis and structure-activity relationships of novel HIV capsid inhibitors with potent antiviral activities.

Design, synthesis and structure-activity relationships of novel HIV capsid inhibitors with potent antiviral activities.

Journal: European journal of medicinal chemistry

Published: March 28, 2025

A patent review of hepatitis B virus core protein allosteric modulators (2019-present).

A patent review of hepatitis B virus core protein allosteric modulators (2019-present).

Journal: Expert opinion on therapeutic patents

Published: February 22, 2025

Discovery of 4-Quinazolinone-Containing Phenylalanine Derivatives as Potent, Resistant-Tolerant HIV Capsid Inhibitors.

Discovery of 4-Quinazolinone-Containing Phenylalanine Derivatives as Potent, Resistant-Tolerant HIV Capsid Inhibitors.

Journal: MedComm

Published: January 07, 2025

"Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency.

"Pseudosubstrate Envelope"/Free Energy Perturbation-Guided Design and Mechanistic Investigations of Benzothiazole HIV Capsid Modulators with High Ligand Efficiency.

Journal: Journal of medicinal chemistry

Published: October 17, 2024

Hydrophobic tagging of small molecules: an overview of the literature and future outlook.

Hydrophobic tagging of small molecules: an overview of the literature and future outlook.

Journal: Expert opinion on drug discovery

Published: June 03, 2024

Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability.

Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability.

Journal: Journal of medicinal chemistry

Published: March 14, 2024

Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators.

Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators.

Journal: Journal of medicinal chemistry

Published: December 06, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026